Candida haemulonii and closely related species at 5 university hospitals in Korea: Identification, antifungal susceptibility, and clinical features

Clinical Infectious Diseases

Volumn 48, Issue 6, 2009, Pages

  Kim, Mi Na ^a   Shin, Jong Hee ^d,e   Sung, Heungsup ^a   Lee, Kyungwon ^b   Kim, Eui Chong ^c   Ryoo, Namhee ^f   Lee, Jin Sol ^d,e   Jung, Sook Ln ^e   Park, Kyung Hwa ^e   Kee, Seung Jung ^d,e   Kim, Soo Hyun ^d,e   Shin, Myung Geun ^d,e   Suh, Soon Pal ^d,e   Ryang, Dong Wook ^d,e  

^a University of Ulsan College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Seoul National University   (South Korea)

^d Chonnam National University ^*  (South Korea)

^e Chonnam National University   (South Korea)

^f Keimyung University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; VORICONAZOLE; ANTIFUNGAL AGENT; FUNGAL DNA; RIBOSOMAL SPACER DNA; RIBOSOME DNA;

ANTIFUNGAL SUSCEPTIBILITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CANDIDA; CANDIDA HAEMULONII; CANDIDA PSEUDOHAEMULONII; CATHETER COMPLICATION; CENTRAL VENOUS CATHETER; CHRONIC OTITIS MEDIA; DISEASE PREDISPOSITION; FUNGAL DETECTION; FUNGEMIA; FUNGUS ISOLATION; GENE SEQUENCE; HUMAN; HUMAN CELL; KOREA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; YEAST; AGED; BLOOD; CANDIDIASIS; CHEMISTRY; CHILD; CLASSIFICATION; CROSS INFECTION; DNA SEQUENCE; DRUG EFFECT; FEMALE; GENETICS; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

AGED; ANTIFUNGAL AGENTS; BLOOD; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DNA, FUNGAL; DNA, RIBOSOMAL; DNA, RIBOSOMAL SPACER; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; KOREA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

EID: 62449106111     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/597108     Document Type: Article

References (15)

1. Gargeya IB, Pruitt WE, Meyer SA, Ahearn DG. Candida haemuhnii from clinical specimens in the USA. I Med Vet Mycol 1991;29:335-8.
2. Lehmann PF, Wu LC, Pruitt WR, Meyer SA, Ahearn DG. Unrelatedness of groups of yeasts within the Candida haemuhnii complex. J Clin Microbiol 1993;31:1683-7.
3. Rodero L, Cuenca-Estrella M, Córdoba S, et al. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemuhnii. I Clin Microbiol 2002;40:2266-9.
4. Khan ZU, Al-Sweih NA, Ahmad S, et al. Outbreak of fungemia among neonates caused by Candida haemuhnii resistant to amphotericin B, itraconazole, and fluconazole. J Clin Microbiol 2007;45:2025-7.
5. Sugita T, Takashima M, Poonwan N, Mekha N. Candida pseudohae-muhnii sp. nov., an amphotericin B- and azole-resistant yeast species, isolated from the blood of a patient from Thailand. Microbiol Immunol 2006; 50:469-73.
6. Shin JH, Chae MJ, Song JW, et al. Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glahrata candidemia. J Clin Microbiol 2007;45:2385-91.
7. Lee IS, Shin IH, Kim MN, et al. Kodamaea ohmeri isolates from patients in a university hospital: identification, antifungal susceptibility, and pulsed-field gel electrophoresis analysis. ] Clin Microbiol 2007; 45: 1005-10.
8. Nguyen MH, Clancy CI, Yu VL, et al. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. } Infect Dis 1998;177:425-30.
9. Clancy CJ, Yu VL, Morris AJ, Snydman DR, Nguyen MH. Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia. Antimicrob Agents Chemother 2005;49:3171-7.
10. Sugita T, Nishikawa A, Ikeda R, Shinoda T. Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification. I Clin Microbiol 1999;37:1985-93.
11. Kurtzman CP, Robnett CI. Identification of clinically important as-comycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997; 35: 1216-23.
12. Pfaller MA, Messer SA, Bolmström A. Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B. Diagn Microbiol Infect Dis 1998; 32:223-7.
13. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard M27-A2. 2nd ed. Wayne, PA: CLSI, 2002.
14. Odds FC, Motyl M, Andrade R, et al. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. I Clin Microbiol 2004;42:3475-82.
15. Pfaller MA, Diekema DJ, Rex JH, et al. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 2006; 44:819-26.